Moreover, glycosylation of IgM correlates with circulating immune cell glycosyltransferase expression of ST3GAL4 and MAN1A2, previously reported clinical markers of COVID-19 severity, and elevations in cytokines IL-16 and IL-18. The gene discussed is CD40LG; the disease is COVID-19.